Potential Role for Stem Cell Regenerative Therapy as a Treatment for Degenerative Disc Disease and Low Back Pain: A Systematic Review
International Journal of Molecular Sciences · 17.05.2023 · 24 (10) · 8893
DOI: 10.3390/ijms24108893 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 17.05.2023. Verfasst von Khadija H Soufi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University of California Davis, Sacramento, CA 95817, USA. Hauptthemen laut MEDLINE: Low Back Pain, Intervertebral Disc Degeneration, Mesenchymal Stem Cell Transplantation, Intervertebral Disc. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 90 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Back pain is the single leading cause of disability worldwide. Despite the prevalence and morbidity of lower back pain, we still lack a gold-standard treatment that restores the physiological function of degenerated intervertebral discs. Recently, stem cells have emerged as a promising strategy for regenerative therapy for degenerative disc disease. In this study, we review the etiology, pathogenesis, and developing treatment strategies for disc degeneration in low back pain with a focus on regenerative stem cell therapies. A systematic search of PubMed/MEDLINE/Embase/Clinical Trials.gov databases was conducted for all human subject abstracts or studies. There was a total of 10 abstracts and 11 clinical studies (1 RCT) that met the inclusion criteria. The molecular mechanism, approach, and progress of the different stem cell strategies in all studies are discussed, including allogenic bone marrow, allogenic discogenic cells, autologous bone marrow, adipose mesenchymal stem cells (MSCs), human umbilical cord MSC, adult juvenile chondrocytes, autologous disc derived chondrocytes, and withdrawn studies. Clinical success with animal model studies is promising; however, the clinical outcomes of stem cell regenerative therapy remain poorly understood. In this systematic review, we found no evidence to support its use in humans. Further studies on efficacy, safety, and optimal patient selection will establish whether this becomes a viable, non-invasive therapeutic option for back pain.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurological Surgery, University of California Davis, Sacramento, CA 95817, USA.
- Department of Anesthesia and Pain Medicine, University of California Davis, Sacramento, CA 95817, USA.
ORCID-Profile: Julius O Ebinu
Zitieren
APA
Soufi, K. H., Castillo, J. A., Rogdriguez, F. Y., DeMesa, C. J., & Ebinu, J. O. (2023). Potential Role for Stem Cell Regenerative Therapy as a Treatment for Degenerative Disc Disease and Low Back Pain: A Systematic Review. International Journal of Molecular Sciences, 24(10), 8893. https://doi.org/10.3390/ijms24108893
Vancouver
Soufi KH, Castillo JA, Rogdriguez FY, DeMesa CJ, Ebinu JO. Potential Role for Stem Cell Regenerative Therapy as a Treatment for Degenerative Disc Disease and Low Back Pain: A Systematic Review. International Journal of Molecular Sciences. 2023;24(10):8893. doi:10.3390/ijms24108893
BibTeX
@article{Soufi2023,
author = {Soufi, Khadija H and Castillo, Jose A and Rogdriguez, Freddie Y and DeMesa, Charles J and Ebinu, Julius O},
title = {Potential Role for Stem Cell Regenerative Therapy as a Treatment for Degenerative Disc Disease and Low Back Pain: A Systematic Review},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {10},
pages = {8893},
doi = {10.3390/ijms24108893}
}
EUVIMED